Abbott Laboratories (SWX:ABT)
Switzerland · Delayed Price · Currency is CHF 99.00
0.00 (0.00%)
At close: Nov 28, 2025
Abbott Laboratories Market Cap
Abbott Laboratories has a market cap or net worth of 180.17 billion as of November 28, 2025. Its market cap has increased by 1.14% in one year.
Market Cap
180.17B
Enterprise Value
184.63B
Revenue
34.96B
Ranking
n/a
PE Ratio
16.23
Stock Price
99.00
Market Cap Chart
Since January 2, 1968, Abbott Laboratories's market cap has increased from 636.28M to 180.17B, an increase of 28,216.24%. That is a compound annual growth rate of 10.23%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Nov 28, 2025 | 180.17B | 1.35% |
| Dec 31, 2024 | 177.78B | 10.48% |
| Dec 29, 2023 | 160.91B | -9.10% |
| Dec 30, 2022 | 177.01B | -19.55% |
| Dec 31, 2021 | 220.03B | 32.56% |
| Dec 31, 2020 | 165.98B | 11.57% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Roche Holding AG | 263.32B |
| Novartis AG | 200.48B |
| Lonza Group AG | 38.40B |
| Galderma Group AG | 37.98B |
| Alcon | 31.37B |
| Sandoz Group AG | 24.43B |
| Straumann Holding AG | 14.91B |
| Sonova Holding AG | 11.99B |